I agree it'll be on the cards at some point, but management or SH's wouldn't accept $57M, would be at substantial premium from this level.
But let's not get into that, let's get GMP ready & have THC product in aussie medicine cabinets & export a sheet load. AND then all congratulate Ken & Co for getting the job done & done well.
unlike some other ramble managements. CPH cracks me up, what a mess.
- Forums
- ASX - By Stock
- EPN
- article
article, page-622
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online